Search results
The Humane Society of the United States and Humane Society Legislative Fund Petition FDA to Revise...
Sierra Sun Times· 4 days agoWASHINGTON — Last week, the Humane Society of the United States and Humane Society Legislative Fund...
FDA grants approval for two Eylea biosimilars for eye conditions
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe US Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf) and Opuviz...
Crab cake recall as life-threatening warning issued
Newsweek· 16 hours agoA crab cake recall has sparked concerns about an undeclared ingredient causing potentially life-threatening allergic reactions. A voluntary recall...
FDA classifies recall of Hologic’s implants for soft tissue as ‘most serious’
WSAU Wausau· 18 hours ago(Reuters) - The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's...
FDA classifies recall of Hologic's implant as 'most serious'
Reuters via Yahoo News· 19 hours agoThe FDA said the recall of the device BioZorb Marker, initiated by Hologic in March, was not a...
FDA Approves Biosimilars for Macular Degeneration Treatment
Healthline via AOL· 22 hours agoThe FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work...
Analysts weigh in on FDA's approval for Amgen's small cell cancer drug By Investing.com
Investing.com· 6 days agoThe U.S. Food and Drug Administration (FDA) on Thursday granted accelerated approval to Amgen's...
FDA Approves New Drug for Deadly Lung Cancer
Alaska Superstation· 6 days agoThe U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer.
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
Market Watch· 3 days agojumped more than 30% Monday morning after the health and wellness platform said it would offer...
FDA Finalizes Rule and Sets Course to Phase In Oversight of Laboratory Developed Tests | JD Supra
JD Supra· 2 days agoOn May 6, 2024, following more than a decade of discourse with interested stakeholders on potential approaches to regulation of laboratory developed tests (LDTs), the U.S. Food and ...